Viewing StudyNCT00038597



Ignite Creation Date: 2024-05-05 @ 11:25 AM
Last Modification Date: 2024-10-26 @ 9:07 AM
Study NCT ID: NCT00038597
Status: COMPLETED
Last Update Posted: 2018-10-30
First Post: 2002-06-03

Brief Title: Phase II Study of SCH66336 A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia CML
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Conditions & Keywords Data

Conditions:
Name
Myelogenous Leukemia Chronic
Keywords:
Name View
Philadelphia chromosome positive CML View
Myelogenous Leukemia Chronic Chronic Phase View
Myelogenous Leukemia Chronic Accelerated Phase View